Comparative ethical evaluation of epigenome editing and genome editing in medicine
First steps and future directions
Bibliographic Data
| ID | 21515004 |
|---|---|
| Authors | Karla Alex (0000-0002-7065-9201, Heidelberg University, corresponding author), Eva C Winkler (0000-0001-7460-0154, Heidelberg University) |
| Year | 2024 |
| Volume | 50 |
| Issue | 6 |
| Pages | 398-406 |
| Publication date | 2024-06-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Medical Ethics (JOURNAL) |
| Journal identifiers | ISSN: 0306-6800 • E-ISSN: 1473-4257 |
| Publisher | BMJ (PUBLISHER • GB) |
| DOI | 10.1136/jme-2022-108888 |
| PMID | 37527926 |
| OpenAlex | W4385453231 |
| Language | EN |
| Citations received | 2 |
| References cited | 100 |
Targeted modifications of the human epigenome, epigenome editing (EE), are around the corner. For EE, techniques similar to genome editing (GE) techniques are used. While in GE the genetic information is changed by directly modifying DNA, intervening in the epigenome requires modifying the configuration of DNA, for example, how it is folded. This does not come with alterations in the base sequence (‘genetic code’). To date, there is almost no ethical debate about EE, whereas the discussions about GE are voluminous. Our article introduces EE into bioethics by translating knowledge from science to ethics and by comparing the risks of EE with those of GE. We, first (I), make the case that a broader ethical debate on EE is due, provide scientific background on EE, compile potential use-cases and recap previous debates. We then (II) compare EE and GE and suggest that the severity of risks of novel gene technologies depends on three factors: (i) the choice of an ex vivo versus an in vivo editing approach, (ii) the time of intervention and intervention windows and (iii) the targeted diseases. Moreover, we show why germline EE is not effective and reject the position of strong epigenetic determinism. We conclude that EE is not always ethically preferable to GE in terms of risks, and end with suggestions for next steps in the current ethical debate on EE by briefly introducing ethical challenges of new areas of preventive applications of EE (III)
Bioethics · Biology · Computational biology · DNA methylation · Engineering ethics · Epigenome · Gene · Genome · Genome editing · Germline · Autism Spectrum Disorder Research · Computer Science · CRISPR and Genetic Engineering · Virus-based gene therapy research · Genetics
Genforschung und Gentherapie im Zeitalter der Genom- und Epigenom-Editierung
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Two kinds of embryo research
Germ-Inating Solutions or Gene-Rating Problems
What Is Prudent Governance of Human Genome Editing
Epigenetic determinism in science and society
Epigenetics, ethics, law and society
From Asilomar to Genome Editing
CRISPR/Cas9 genome editing – new and old ethical issues arising from a revolutionary technology
Gene Editing, Identity and Benefit
| Citations per year | 1 |
|---|---|
| Citation span | 2024 - 2025 (2) |
| Highly cited | No |